Locations
Paris, France · Île-de-France, France
industry
Data and Analytics · DeepTech · Health · Software
Size
1 - 10 employees
Stage
Seed
founded in
2019
Im Vitro is a pioneering medical device company that develops EMBRYOLY, an AI-powered SaaS platform designed for embryo management in in vitro fertilization (IVF) labs. The platform enhances lab efficiency, increases pregnancy rates, and reduces costs by automating administrative tasks and providing real-time performance tracking. With a unique database equivalent to over 50 years of embryology, EMBRYOLY integrates seamlessly with various time-lapse microscopes and is backed by scientific research, including peer-reviewed publications. The company has established a strong market position in Europe, with numerous IVF clinics already utilizing its technology, demonstrating significant traction and positive outcomes in patient care.
Something looks off?